Stay updated on SNDX-6352 in Active cGVHD Clinical Trial
Sign up to get notified when there's something new on the SNDX-6352 in Active cGVHD Clinical Trial page.

Latest updates to the SNDX-6352 in Active cGVHD Clinical Trial page
- Check5 days agoChange DetectedThe site's revision label was updated from v3.4.2 to v3.4.3.SummaryDifference0.0%

- Check12 days agoNo Change Detected
- Check19 days agoNo Change Detected
- Check34 days agoChange DetectedAdded Revision: v3.4.2. Removed the funding-lapse notice and Revision: v3.4.1.SummaryDifference0.4%

- Check41 days agoChange DetectedA new notice about a lapse in government funding and NIH facility status was added, including guidance to visit opm.gov. The page now shows Revision: v3.4.1 (replacing v3.4.0).SummaryDifference0.4%

- Check48 days agoChange DetectedShow glossary was added and new metadata labels were introduced (Last Update Submitted that Met QC Criteria, Last Update Posted), along with No FEAR Act Data and Revision: v3.4.0.SummaryDifference0.2%

- Check62 days agoChange DetectedRevision: v3.3.4 replaces the previous v3.3.3 in the page metadata. No changes to study content are observed.SummaryDifference0.0%

- Check83 days agoChange DetectedAdded a Locations section listing study sites in Alabama, California, Florida, Indiana, Massachusetts, Michigan, Minnesota, Missouri, Tennessee, Utah, and Washington, and updated the page revision to v3.3.3.SummaryDifference1%

Stay in the know with updates to SNDX-6352 in Active cGVHD Clinical Trial
Enter your email address, and we'll notify you when there's something new on the SNDX-6352 in Active cGVHD Clinical Trial page.